Alkermes' (ALKS) Nemvaleukin Alfa Granted FDA Fast Track Designation
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| ALKERMES (NASDAQ: ALKS) | Delayed: 43.63 -0.55 (1.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $44.18 | 52 Week High | $80.71 | |||
| Open | $44.15 | 52 Week Low | $27.14 | |||
| Day High | $44.15 | P/E | 335.62 | |||
| Day Low | $43.15 | EPS | $0.13 | |||
| Volume | 884,768 | |||||
